Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Operating Expenses: 2011-2025

Historic Operating Expenses for Aytu Biopharma (AYTU) over the last 15 years, with Jun 2025 value amounting to $53.7 million.

  • Aytu Biopharma's Operating Expenses fell 17.23% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.4 million, marking a year-over-year increase of 3.58%. This contributed to the annual value of $53.7 million for FY2025, which is 5.95% up from last year.
  • According to the latest figures from FY2025, Aytu Biopharma's Operating Expenses is $53.7 million, which was up 5.95% from $50.6 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Operating Expenses ranged from a high of $162.2 million in FY2022 and a low of $50.6 million during FY2024.
  • Moreover, its 3-year median value for Operating Expenses was $53.7 million (2025), whereas its average is $62.7 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 117.55% in 2021, then plummeted by 48.40% in 2023.
  • Aytu Biopharma's Operating Expenses (Yearly) stood at $88.1 million in 2021, then surged by 84.16% to $162.2 million in 2022, then slumped by 48.40% to $83.7 million in 2023, then plummeted by 39.49% to $50.6 million in 2024, then climbed by 5.95% to $53.7 million in 2025.